Loading clinical trials...

Acupuncture Lowering Blood Pressure for Secondary Prevention of Stroke | Clinical Trials | Clareo Health

UNKNOWNNA

Acupuncture Lowering Blood Pressure for Secondary Prevention of Stroke

Acupuncture Lowering Blood Pressure for Secondary Prevention of Stroke: Study Protocol for a Multicenter, Pragmatic,Randomized Controlled, Assessor-blinded Clinical Trial

NCT02967484•First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

View on ClinicalTrials.gov

Summary

This study evaluate the effects of acupuncture method on the recurrence of ischemic stroke patients.Half of participants will receive "Huo Xue San Feng" acupuncture combining 1 antihypertensive medication on the routine ischemic stroke treatments' basis. While the other half will receive 1 antihypertensive medication and basic treatments for ischemic stroke.

Detailed Description

Under recuiting 480 patients come from 5 hospitals in China.Eligible patients will be randomly assigned into 2 groups: treatment group and control group. The treatment group will receive "Huo Xue San Feng" acupuncture combining 1 antihypertensive medication on the routine ischemic stroke treatments' basis. The control group will receive 1 antihypertensive medication and basic treatments for ischemic stroke. "Huo Xue San Feng" acupuncture will be given six sessions weekly for the first 6 weeks and three times weekly for the next 6 weeks. A 9-month follow-up will thereafter be conducted. Antihypertensive medications will be adjusted based on BP levels.

Eligibility

Age

35 - 75 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Patients with the first time ischemic stroke
•Patients meet the TCM diagnosis standard of Stroke
•Patients meet the diagnosis standard of hypertension, taking only 1 type of antihypertensive drugs for at least 2 weeks before admission,corresponding to systolic pressure ranging from 140 to 160mmHg and Diastolic ranging from 90-100mmHg.
•The course of Ischemic stroke ranging from 2 weeks to 6 weeks .
•Men or Women Aged between 35 and 70 years old.
•Patients who are willing to participate in our clinical trial agree to sign the informed consent form.

Exclusion Criteria

•Patients who have been diagnosed with secondary hypertension.
•Patients have taken beta blockers or diuretics or non dihydropyridine calcium channel blocker （NDHP-CCB）for a long time because of cardiovascular disease.
•Patients who taking 1 type of antihypertensive drugs,blood pressure under 140/90mmHg.
•Patients accompanied with other neurological disorders,such as epilepsy, peripheral nerve injury,
•Patients accompanied with severe medical condition such as severe hematopoietic system disease, coagulation dysfunction and malignant tumor.
•Patients accompanied with diabetic nephropathy,severe liver and renal insufficiency,severe cardiac or pulmonary dysfunction,severe arrhythmia.
•Patients who have occured skin infections near the acupoint location.
•Pregnant or breast-feeding women.
•Patients who currently participate in another clinical trial.

Locations (5)

Chongqing Traditional Chinese Medicine Hospital

Chongqing, China

MIANYANG Hospital of Traditional Chinese Medicine

Mianyang, China

LONGHUA Hospital Shanghai University of Traditional Chinese Medicine

Shanghai, China

Shenzhen Bao'an Traditional Chinese Medicine Hospital Group

Shenzhen, China

First Teaching Hospital of Tianjin University of TCM

Tianjin, China

Key Dates

Start Date

November 20, 2016

Primary Completion Date

May 1, 2020

Completion Date

May 1, 2020

Last Updated

July 26, 2017

Enrollment

480

ESTIMATED participants

Conditions

Cerebral Infarction

Interventions

acupuncture

DEVICE

Contacts

yuzheng Du

CONTACT

13702088266 drduyuzheng11@163.com

The Effect and Safety of Combined Anti-platelet Treatment in Acute Ischemic Stroke Due to Large Artery Atherosclerosis

NCT06757764

Cerebral InfarctionStenosis Artery

View study

ACTIVE_NOT_RECRUITINGNA

Observation of the Therapeutic Effect of Fire Needle on Upper Limb Function in Stroke Patients

NCT07140406

Cerebral Infarction

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 26, 2017Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Acupuncture Lowering Blood Pressure for Secondary Prevention of Stroke

Inclusion Criteria

Exclusion Criteria

The Effect and Safety of Combined Anti-platelet Treatment in Acute Ischemic Stroke Due to Large Artery Atherosclerosis

Observation of the Therapeutic Effect of Fire Needle on Upper Limb Function in Stroke Patients

Traditional Chinese Medicine Intervention for Ischemic Cerebrovascular Disease and Diabetes Mellitus: An Efficacy Comparative Study

The Safety and Efficacy of Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-ACI) in the Treatment of Acute Cerebral Infarction

The Application of Kinesio Taping Technique in the Early Upper Limb Functional Activities Induction of Hemiplegic Patients After Stroke

Effects of Armeo Power Robot Therapy on Upper Limb Recovery in Hemiplegic Stroke Patients